PaccMann^RL: Designing Anticancer Drugs with Reinforcement Learning w/ Jannis Born

https://cdn.twimlai.com/wp-content/uploads/2020/01/23155024/TWIML_COVER_800x800_JB.jpg 800 800 The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence) The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence) https://cdn.twimlai.com/wp-content/uploads/2020/01/23155024/TWIML_COVER_800x800_JB.jpg January 23, 2020 January 28, 2020

January 23, 2020
no comments

Today we’re joined by Jannis Born, Ph.D. student at ETH & IBM Research Zurich.

Subscribe: iTunes / Google Play / Spotify / RSS

We caught up with Jannis a few weeks back at NeurIPS, where he was presenting his poster on “PaccMann^RL: Designing anticancer drugs from transcriptomic data via reinforcement learning,” a framework built to accelerate new anticancer drug discovery. In our conversation, Jannis details how his background in cognitive science and computational neuroscience applies to his current ML research. We then transition into a conversation about PaccMann, or Prediction of Anticancer Compound Sensitivity with Multimodal Attention-based Neural Networks, discussing how reinforcement learning fits into the goal of cancer drug discovery, how deep learning has changed this research, interesting observations made during the training of their DRL learner, and of course, Jannis offers us a step-by-step walkthrough of how the framework works to predict the sensitivity of cancer drugs on a cell and then discover new anticancer drugs.

Community Update

We’re excited to announce a couple of new study group offerings in conjunction with our ever-expanding array of TWIML Community programs. One is focused on causality and the other on enterprise AI workflows. Click here to learn more about these programs!